GTS Securities’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-18,204
Closed -$120K 4070
2023
Q4
$122K Sell
18,204
-3,781
-17% -$21.3K ﹤0.01% 3705
2023
Q3
$124K Sell
21,985
-7,319
-25% -$48.8K ﹤0.01% 3558
2023
Q2
$162K Buy
+29,304
New +$158K 0.01% 1070

Other funds holding GDRX

GTS Securities's GDRX Position: Q1 2024 in Review

GTS Securities sold out of GoodRx Holdings (GDRX) in Q1 2024, closing a stake of 18,204 shares — an estimated $120K sold.

GTS Securities first reported a position in GDRX in Q2 2023 and held it in 3 quarters. The position peaked at $162K in Q2 2023. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2024.

  • GTS Securities reported no remaining GoodRx Holdings position as of Q1 2024 after selling out during the quarter.
  • GTS Securities sold 18,204 GoodRx Holdings shares in Q1 2024, an estimated $120K.
  • GTS Securities first reported a position in GoodRx Holdings in Q2 2023 and held it in 3 quarters.
  • GTS Securities's GoodRx Holdings position peaked at $162K in Q2 2023.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2024.

Based on GTS Securities's 13F filing for Q1 2024, filed 15 May 2024.